Penumbra’s stock was up about 12% after the deal was announced Thursday morning.
www.marketwatch.com
#Boston #Scientific #buying #Penumbra #billion #business #removing #blood #clots
Boston Scientific is buying Penumbra for $14.5 billion to get into the business of removing blood clots
